Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00232648 | Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma | PHASE3 | COMPLETED | 54 | — | — | Jan 1, 2004 | Nov 1, 2006 | Mar 25, 2009 | 9 | Japan |
| Name | Type | Description |
|---|---|---|
| Pulmicort (budesonide) Respules | DRUG | - |
Inclusion Criteria: \- 1. Clinical benefit from continued treatment with budesonide inhalation suspension was expected in patients with bronchial asthma participating in study SD-004-0765, as judged by the investigator(s) at the completion of that study (Visit 11, Week 24), and the patient's caregi...